BioCentury | Oct 5, 2009
Company News

Paladin, Quest Pharma deal

...combined with chemotherapeutics, photodynamic therapies or radioimmunotherpay. Paladin gained the mAbs through its acquisition of ViRexx Medical Corp....
BioCentury | Jan 5, 2009
Company News

Paladin, ViRexx Medical infectious news

...Queen's Bench of Alberta (see BioCentury, Dec. 22, 2008). Paladin Labs Inc. (TSX:PLB), Montreal, Quebec ViRexx Medical Corp....
BioCentury | Dec 22, 2008
Company News

Paladin, ViRexx Medical infectious news

...testing to treat HBV infection (see BioCentury, Sept. 22). Paladin Labs Inc. (TSX:PLB), Montreal, Quebec ViRexx Medical Corp....
BioCentury | Sep 22, 2008
Company News

ViRexx Medical cancer, infectious news

...had C$756,812 (US$743,039) in cash and a six-month operating loss of C$3.2 million (US$3.1 million). ViRexx Medical Corp....
BioCentury | Apr 14, 2008
Company News

ViRexx Medical board of directors update

ViRexx Medical Corp. (TSX:VIR; AMEX:REX), Edmonton, Alberta Business: Cancer, Infectious Departed: Peter Smetek Jr. WIR Staff cancer Infectious...
BioCentury | Dec 10, 2007
Clinical News

OvaRex oregovomab: Phase III data

...and return rights to all compounds to VIR. United Therapeutics Corp. (UTHR), Silver Spring, Md. ViRexx Medical Corp....
BioCentury | Oct 22, 2007
Company News

ViRexx Medical management update

ViRexx Medical Corp. (TSX:VIR; REX), Edmonton, Alberta Business: Cancer, Infectious Hired: Erich Bam as interim COO, formerly a partner and managing director of Gemini Partners Inc.; he replaces Marc Canton, who departed WIR Staff...
BioCentury | Oct 1, 2007
Company News

ViRexx Medical management update

ViRexx Medical Corp. (TSX:VIR; REX), Edmonton, Alberta Business: Cancer, Infectious Appointed: Darrell Elliott, chairman of Tekmira Pharmaceuticals Corp. and Chromos Molecular Systems Inc. , as chairman and interim CEO; he replaces Peter Smetek, who will remain...
BioCentury | Jun 18, 2007
Clinical News

OvaRex oregovomab: Phase II data

...partnered with UTHR in the U.S. and Canada. United Therapeutics Corp. (UTHR), Silver Spring, Md. ViRexx Medical Corp....
BioCentury | Jun 4, 2007
Company News

ViRexx Medical, National Research Council of Canada infectious news

...company also has a Chimigen HCV vaccine in preclinical development. Further terms were not disclosed. ViRexx Medical Corp....
Items per page:
1 - 10 of 35
BioCentury | Oct 5, 2009
Company News

Paladin, Quest Pharma deal

...combined with chemotherapeutics, photodynamic therapies or radioimmunotherpay. Paladin gained the mAbs through its acquisition of ViRexx Medical Corp....
BioCentury | Jan 5, 2009
Company News

Paladin, ViRexx Medical infectious news

...Queen's Bench of Alberta (see BioCentury, Dec. 22, 2008). Paladin Labs Inc. (TSX:PLB), Montreal, Quebec ViRexx Medical Corp....
BioCentury | Dec 22, 2008
Company News

Paladin, ViRexx Medical infectious news

...testing to treat HBV infection (see BioCentury, Sept. 22). Paladin Labs Inc. (TSX:PLB), Montreal, Quebec ViRexx Medical Corp....
BioCentury | Sep 22, 2008
Company News

ViRexx Medical cancer, infectious news

...had C$756,812 (US$743,039) in cash and a six-month operating loss of C$3.2 million (US$3.1 million). ViRexx Medical Corp....
BioCentury | Apr 14, 2008
Company News

ViRexx Medical board of directors update

ViRexx Medical Corp. (TSX:VIR; AMEX:REX), Edmonton, Alberta Business: Cancer, Infectious Departed: Peter Smetek Jr. WIR Staff cancer Infectious...
BioCentury | Dec 10, 2007
Clinical News

OvaRex oregovomab: Phase III data

...and return rights to all compounds to VIR. United Therapeutics Corp. (UTHR), Silver Spring, Md. ViRexx Medical Corp....
BioCentury | Oct 22, 2007
Company News

ViRexx Medical management update

ViRexx Medical Corp. (TSX:VIR; REX), Edmonton, Alberta Business: Cancer, Infectious Hired: Erich Bam as interim COO, formerly a partner and managing director of Gemini Partners Inc.; he replaces Marc Canton, who departed WIR Staff...
BioCentury | Oct 1, 2007
Company News

ViRexx Medical management update

ViRexx Medical Corp. (TSX:VIR; REX), Edmonton, Alberta Business: Cancer, Infectious Appointed: Darrell Elliott, chairman of Tekmira Pharmaceuticals Corp. and Chromos Molecular Systems Inc. , as chairman and interim CEO; he replaces Peter Smetek, who will remain...
BioCentury | Jun 18, 2007
Clinical News

OvaRex oregovomab: Phase II data

...partnered with UTHR in the U.S. and Canada. United Therapeutics Corp. (UTHR), Silver Spring, Md. ViRexx Medical Corp....
BioCentury | Jun 4, 2007
Company News

ViRexx Medical, National Research Council of Canada infectious news

...company also has a Chimigen HCV vaccine in preclinical development. Further terms were not disclosed. ViRexx Medical Corp....
Items per page:
1 - 10 of 35